Author:
Papavassiliou Kostas A.,Gargalionis Antonios N.,Papavassiliou Athanasios G.
Reference7 articles.
1. Direct and selective pharmacological disruption of the YAP-TEAD interface by IAG933 inhibits Hippo-dependent and RAS-MAPK-altered cancers;Chapeau;Nat. Cancer,2024
2. Direct inhibition of the YAP:TEAD interaction: an unprecedented drug discovery challenge;Chene;ChemMedChem,2024
3. The first class of small molecules potently disrupting the YAP-TEAD interaction by direct competition;Furet;ChemMedChem,2022
4. YAP/TAZ signaling and resistance to cancer therapy;Nguyen;Trends Cancer,2019
5. TEAD inhibition overcomes YAP1/TAZ-driven primary and acquired resistance to KRASG12C inhibitors;Edwards;Cancer Res,2023